Review
A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm
- PMID: 21068703
Item in Clipboard
Review
A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm
Med Lett Drugs Ther.
.
Abstract
The FDA has approved incobotulinumtoxinA (Xeomin--Merz) for treatment of cervical dystonia and blepharospasm in adults. It has been commercially available in Germany since 2005. Several formulations of botulinum toxin type A (Botox; Dysport) and type B (Myobloc) are already marketed for treatment of cervical dystonia. Botox is also approved for treatment of blepharospasm.
Similar articles
-
A guide to dosing in the treatment of cervical dystonia and blepharospasm with Xeomin®: a new botulinum neurotoxin A.Parkinsonism Relat Disord. 2012 Jun;18(5):441-5. doi: 10.1016/j.parkreldis.2012.02.008. Epub 2012 Mar 9. Parkinsonism Relat Disord. 2012. PMID: 22405829 Review.
-
Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.Curr Med Res Opin. 2005 Mar;21(3):433-8. doi: 10.1185/030079905X36396. Curr Med Res Opin. 2005. PMID: 15811212 Clinical Trial.
-
[Treatment of focal dystonia with botulinum toxin A].Wien Klin Wochenschr. 2001;113 Suppl 4:6-10. Wien Klin Wochenschr. 2001. PMID: 15506045 Review. German.
-
Dystonia and headaches: clinical features and response to botulinum toxin therapy.Adv Neurol. 2004;94:321-8. Adv Neurol. 2004. PMID: 14509690 No abstract available.
-
[Focal dystonias and facial hemispasm: treatment with botulinum A toxin].Arch Neurobiol (Madr). 1991;54 Suppl 3:44-51. Arch Neurobiol (Madr). 1991. PMID: 1810208 Spanish.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
